Chronic Kidney Disease (CKD) impacts more than 1 in 7 adults in the United States, totaling roughly 37 million people. March is National Kidney Disease Month – an important awareness initiative, as up to 90% of those with CKD are unaware of their condition. Data, analytics, and research play a critical role in identifying risk factors, understanding disease progression and developing life-changing drugs, to improve care and quality of life. In honor of those suffering from chronic kidney disease, Truveta looks at how Truveta Data can deliver fast insights for those suffering from CKD.
Within Truveta Studio, there are roughly 4 million CKD patient journeys ready for discovery and analysis. This includes over 1.6 million patients with at least one hospitalization, 2.7 million patients with lab data supporting a diagnosis of CKD, and 1.9 million CKD patients aged 65 and older.
Truveta Prose definition for CKD by condition code for patients aged 65 and older, taken from Truveta Studio.
CKD Patient Journey: Bringing the data to life
Faster insights to drive better care
Kidney transplants have spiked to record levels in recent years, reaching nearly 25,000 in 2021. There are another 90,000 on the waiting list; the vast majority of the organ donation wait list in the country.
Truveta can help deliver insights to help researchers learn how to advance care for these patients more rapidly – shrinking the time to insight from months to days. Now is the time for novel insights to advance CKD patient care and outcomes.